Mast cells promote atherosclerosis by releasing proinflammatory cytokines

[1]  Christoph Peters,et al.  Cathepsin L Deficiency Reduces Diet-Induced Atherosclerosis in Low-Density Lipoprotein Receptor-Knockout Mice , 2007, Circulation.

[2]  I. van der Made,et al.  Disruption of the Cathepsin K Gene Reduces Atherosclerosis Progression and Induces Plaque Fibrosis but Accelerates Macrophage Foam Cell Formation , 2005, Circulation.

[3]  C. Chen,et al.  Mast cell-deficient W-sash c-kit mutant Kit W-sh/W-sh mice as a model for investigating mast cell biology in vivo. , 2005, The American journal of pathology.

[4]  M. Åbrink,et al.  A Key Role for Mast Cell Chymase in the Activation of Pro-matrix Metalloprotease-9 and Pro-matrix Metalloprotease-2* , 2005, Journal of Biological Chemistry.

[5]  P. Wolters,et al.  Tissue‐selective mast cell reconstitution and differential lung gene expression in mast cell‐deficient KitW‐sh/KitW‐sh sash mice , 2005, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[6]  A. Luttun,et al.  Loss of Matrix Metalloproteinase-9 or Matrix Metalloproteinase-12 Protects Apolipoprotein E–Deficient Mice Against Atherosclerotic Media Destruction but Differentially Affects Plaque Growth , 2004, Circulation.

[7]  M. Åbrink,et al.  The Chymase, Mouse Mast Cell Protease 4, Constitutes the Major Chymotrypsin-like Activity in Peritoneum and Ear Tissue. A Role for Mouse Mast Cell Protease 4 in Thrombin Regulation and Fibronectin Turnover , 2003, The Journal of experimental medicine.

[8]  P. Libby,et al.  Deficiency of the Cysteine Protease Cathepsin S Impairs Microvessel Growth , 2003, Circulation research.

[9]  Makoto Naito,et al.  Deficiency of cathepsin S reduces atherosclerosis in LDL receptor-deficient mice. , 2003, The Journal of clinical investigation.

[10]  P. Libby.  Inflammation in atherosclerosis , 2002, Nature.

[11]  K. Austen,et al.  The Diverse Roles of Mast Cells , 2001, The Journal of experimental medicine.

[12]  S. Galli,et al.  Mast Cells Can Amplify Airway Reactivity and Features of Chronic Inflammation in an Asthma Model in Mice , 2000, The Journal of experimental medicine.

[13]  D. Hanahan,et al.  Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. , 1999, Genes & development.

[14]  G. Angelini,et al.  Activation of matrix-degrading metalloproteinases by mast cell proteases in atherosclerotic plaques. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[15]  P. Libby,et al.  Reduction of atherosclerosis in mice by inhibition of CD40 signalling , 1998, Nature.

[16]  D. Woolley,et al.  MAST CELL DISTRIBUTION, ACTIVATION, AND PHENOTYPE IN ATHEROSCLEROTIC LESIONS OF HUMAN CAROTID ARTERIES , 1997, The Journal of pathology.

[17]  P. Kovanen,et al.  Mast cells in rupture-prone areas of human coronary atheromas produce and store TNF-alpha. , 1996, Circulation.

[18]  S. Lazarus,et al.  Dog mastocytoma cells secrete a 92-kD gelatinase activated extracellularly by mast cell chymase. , 1996, The Journal of clinical investigation.

[19]  P. Bradding.  Human mast cell cytokines , 1996, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[20]  P. Libby,et al.  Microscopic localization of active proteases by in situ zymography: detection of matrix metalloproteinase activity in vascular tissue , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[21]  A. Zelenetz,et al.  The Wsh and Ph mutations affect the c-kit expression profile: c-kit misexpression in embryogenesis impairs melanogenesis in Wsh and Ph mutant mice. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[22]  G. K. Iwamoto,et al.  Interferon-gamma regulation of interleukin 6 in monocytic cells. , 1994, The American journal of physiology.

[23]  D K Burns,et al.  Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice. , 1994, The Journal of clinical investigation.

[24]  S. Nishikawa,et al.  c-kit Gene was not transcribed in cultured mast cells of mast cell-deficient Wsh/Wsh mice that have a normal number of erythrocytes and a normal c-kit coding region. , 1992, Blood.

[25]  D. Rich,et al.  Molecular cloning and expression of human alveolar macrophage cathepsin S, an elastinolytic cysteine protease. , 1992, The Journal of biological chemistry.

[26]  K. Austen,et al.  Differential expression of secretory granule proteases in mouse mast cells exposed to interleukin 3 and c-kit ligand , 1992, The Journal of experimental medicine.

[27]  P. Constantinides.  Mast cells and susceptibility to experimental atherosclerosis. , 1953, Science.

[28]  B. Ryffel,et al.  Distinct and nonredundant in vivo functions of TNF produced by t cells and macrophages/neutrophils: protective and deleterious effects. , 2005, Immunity.

[29]  M. Tsai,et al.  Mast cells as "tunable" effector and immunoregulatory cells: recent advances. , 2005, Annual review of immunology.